anurajms/meta_analysis huggingface dataset:
MESH terms:
Interventions for the cessation of non‐nutritive sucking habits in children
1. Bedding and Linens; 2. Fingersucking [psychology, *therapy]; 3. Malocclusion [etiology, prevention & control]; 4. *Orthodontic Appliances; 5. Orthodontic Appliances, Functional; 6. Pacifiers; 7. *Reinforcement, Psychology; 8. Stress, Psychological [prevention & control]; 9. *Sucking Behavior;
MESH terms:
Intraoperative local anaesthesia for reduction of postoperative pain following general anaesthesia for dental treatment in children and adolescents
1. *Anesthesia, General; 2. *Anesthesia, Local; 3. Anesthetics, Local [*administration & dosage]; 4. Bupivacaine; 5. Dental Care [*adverse effects]; 6. Epinephrine; 7. Felypressin; 8. Intraoperative Care [methods]; 9. Lidocaine; 10. Pain, Postoperative [*prevention & control]; 11. Postoperative Hemorrhage [prevention & control]; 12. Prilocaine; 13. Randomized Controlled Trials as Topic;
MESH terms:
Powered versus manual toothbrushing for oral health
1. Dental Devices, Home Care [*adverse effects, *economics]; 2. Dental Plaque [complications, *prevention & control]; 3. Gingival Diseases [prevention & control]; 4. Gingivitis [*prevention & control]; 5. Oral Health; 6. Periodontal Diseases [prevention & control]; 7. Randomized Controlled Trials as Topic; 8. Toothbrushing [*instrumentation, methods];
MESH terms:
Triclosan/copolymer containing toothpastes for oral health
1. Anti‐Infective Agents, Local [*administration & dosage]; 2. Dental Calculus [prevention & control]; 3. Dental Caries [prevention & control]; 4. Dental Plaque [prevention & control]; 5. Gingivitis [prevention & control]; 6. Oral Hygiene [*methods]; 7. Periodontitis [prevention & control]; 8. Randomized Controlled Trials as Topic; 9. Toothpastes [*chemistry]; 10. Triclosan [*administration & dosage];
MESH terms:
Enamel etching for bonding fixed orthodontic braces
1. *Orthodontic Brackets; 2. Acid Etching, Dental [adverse effects, *methods]; 3. Cementation [adverse effects, *methods]; 4. Randomized Controlled Trials as Topic; 5. Tooth Demineralization [chemically induced];
MESH terms:
Interventions for replacing missing teeth: antibiotics at dental implant placement to prevent complications
1. *Dental Restoration Failure; 2. Amoxicillin [administration & dosage]; 3. Anti‐Bacterial Agents [administration & dosage]; 4. Antibiotic Prophylaxis [*adverse effects]; 5. Bacterial Infections [*prevention & control]; 6. Dental Implants [*adverse effects]; 7. Drug Administration Schedule; 8. Jaw, Edentulous, Partially [*surgery]; 9. Randomized Controlled Trials as Topic;
MESH terms:
Fluoride varnishes for preventing dental caries in children and adolescents
1. Dental Caries [*prevention & control]; 2. Dentition, Permanent; 3. Fluorides, Topical [*administration & dosage, adverse effects]; 4. Mouth, Edentulous [epidemiology]; 5. Randomized Controlled Trials as Topic; 6. Tooth, Deciduous;
MESH terms:
Psychosocial interventions for survivors of rape and sexual assault experienced during adulthood
1. Behavior Therapy; 2. *Cognitive Behavioral Therapy [methods]; 3. Psychosocial Intervention; 4. Psychotherapy [methods]; 5. *Rape;
MESH terms:
Interventions from pregnancy to two years after birth for parents experiencing complex post‐traumatic stress disorder and/or with childhood experience of maltreatment
1. Mothers [education]; 2. Parents [education]; 3. Pregnant Women; 4. Psychotherapy [methods]; 5. *Stress Disorders, Post-Traumatic [therapy];
MESH terms:
Crisis interventions for adults with borderline personality disorder
1. *Borderline Personality Disorder [therapy]; 2. Crisis Intervention; 3. Hospitalization; 4. Quality of Life; 5. *Self-Injurious Behavior [therapy];
MESH terms:
Medications for daytime sleepiness in individuals with idiopathic hypersomnia
1. Bias; 2. Clarithromycin [*therapeutic use]; 3. Disorders of Excessive Somnolence [*drug therapy, etiology]; 4. Idiopathic Hypersomnia [*complications]; 5. Modafinil [*therapeutic use]; 6. Placebos [therapeutic use]; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Wakefulness; 10. Wakefulness-Promoting Agents [*therapeutic use];
MESH terms:
Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
1. Antidepressive Agents, Second-Generation [administration & dosage]; 2. Anxiety [drug therapy]; 3. Attention Deficit Disorder with Hyperactivity [*drug therapy]; 4. Bias; 5. Bupropion [administration & dosage]; 6. Central Nervous System Stimulants [*administration & dosage, adverse effects]; 7. Depression [drug therapy]; 8. Drug Delivery Systems; 9. Flavonoids [administration & dosage]; 10. Lithium Compounds [administration & dosage]; 11. Methylphenidate [*administration & dosage, adverse effects]; 12. Placebos [administration & dosage]; 13. Plant Extracts [administration & dosage]; 14. Randomized Controlled Trials as Topic [statistics & numerical data];
MESH terms:
Psychological interventions to foster resilience in healthcare students
1. Allied Health Occupations [education]; 2. Allied Health Personnel [psychology]; 3. Anxiety [diagnosis]; 4. Bias; 5. Depression [diagnosis]; 6. Mental Health; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. *Resilience, Psychological; 10. Stress, Psychological [diagnosis]; 11. Students, Health Occupations [*psychology]; 12. Waiting Lists;
MESH terms:
Speech and language therapy for management of chronic cough
1. *Language Therapy; 2. *Speech Therapy; 3. Chronic Disease; 4. Cough [*therapy]; 5. Physical Therapy Modalities; 6. Randomized Controlled Trials as Topic;
MESH terms:
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults
1. Amphetamines [*therapeutic use]; 2. Attention Deficit Disorder with Hyperactivity [*drug therapy]; 3. Central Nervous System Stimulants [*therapeutic use]; 4. Dextroamphetamine [therapeutic use]; 5. Lisdexamfetamine Dimesylate [therapeutic use]; 6. Randomized Controlled Trials as Topic;
MESH terms:
De‐escalation techniques for managing non‐psychosis induced aggression in adults
1. *Aggression; 2. Crisis Intervention; 3. Dementia [*psychology]; 4. France; 5. Multicenter Studies as Topic;
MESH terms:
Antidepressants for insomnia in adults
1. Antidepressive Agents [adverse effects, *therapeutic use]; 2. Antidepressive Agents, Tricyclic [adverse effects, therapeutic use]; 3. Fluoxetine [adverse effects, therapeutic use]; 4. Mianserin [adverse effects, therapeutic use]; 5. Paroxetine [adverse effects, therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Selective Serotonin Reuptake Inhibitors [adverse effects, therapeutic use]; 8. Sleep Initiation and Maintenance Disorders [*drug therapy]; 9. Trazodone [adverse effects, therapeutic use];
MESH terms:
Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults
1. Anxiety Disorders [therapy]; 2. Attention Deficit Disorder with Hyperactivity [drug therapy, *therapy]; 3. Cognitive Behavioral Therapy [*methods]; 4. Depression [therapy]; 5. Diagnostic Self Evaluation; 6. Randomized Controlled Trials as Topic; 7. Waiting Lists;
MESH terms:
Point‐of‐use fortification of foods with micronutrient powders containing iron in children of preschool and school‐age
1. Anemia, Iron-Deficiency [blood, prevention & control, *therapy]; 2. Dietary Supplements; 3. Edetic Acid [administration & dosage]; 4. Ferric Compounds [administration & dosage]; 5. Ferrous Compounds [administration & dosage]; 6. *Food, Fortified [adverse effects]; 7. Iron [*administration & dosage]; 8. Micronutrients [*administration & dosage, adverse effects]; 9. Point-of-Care Systems; 10. Powders; 11. Trace Elements [administration & dosage]; 12. Vitamins [administration & dosage];
MESH terms:
Methylphenidate for children and adolescents with autism spectrum disorder
1. Attention Deficit Disorder with Hyperactivity [*drug therapy]; 2. Autism Spectrum Disorder [*drug therapy]; 3. Central Nervous System Stimulants [*therapeutic use]; 4. Cross‐Over Studies; 5. Methylphenidate [*therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Treatment Outcome;
MESH terms:
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults
1. Attention Deficit Disorder with Hyperactivity [*drug therapy]; 2. Bupropion [administration & dosage, adverse effects, *therapeutic use]; 3. Central Nervous System Stimulants [administration & dosage, adverse effects, *therapeutic use]; 4. Delayed‐Action Preparations; 5. Off‐Label Use; 6. Patient Dropouts [statistics & numerical data]; 7. Randomized Controlled Trials as Topic; 8. Severity of Illness Index; 9. Treatment Outcome;
MESH terms:
Atypical antipsychotics for disruptive behaviour disorders in children and youths
1. Aggression [*drug effects]; 2. Antipsychotic Agents [adverse effects, *therapeutic use]; 3. Anxiety Disorders [drug therapy]; 4. Attention Deficit and Disruptive Behavior Disorders [*drug therapy]; 5. Attention Deficit Disorder with Hyperactivity [drug therapy]; 6. Conduct Disorder [drug therapy]; 7. Depressive Disorder, Major [drug therapy]; 8. Dibenzothiazepines [adverse effects, *therapeutic use]; 9. Piperazines [*therapeutic use]; 10. Quetiapine Fumarate [*therapeutic use]; 11. Randomized Controlled Trials as Topic; 12. Risperidone [adverse effects, *therapeutic use]; 13. Thiazoles [*therapeutic use]; 14. Weight Gain;
MESH terms:
Task‐oriented interventions for children with developmental co‐ordination disorder
1. Activities of Daily Living; 2. Motor Skills Disorders [*therapy]; 3. Movement Disorders [therapy]; 4. Non‐Randomized Controlled Trials as Topic [statistics & numerical data]; 5. Randomized Controlled Trials as Topic [statistics & numerical data]; 6. Social Skills; 7. Task Performance and Analysis;
MESH terms:
Treadmill interventions in children under six years of age at risk of neuromotor delay
1. *Body Weight; 2. Cerebral Palsy [complications, rehabilitation]; 3. Child Development [physiology]; 4. Dependent Ambulation; 5. Down Syndrome [complications, rehabilitation]; 6. Exercise Movement Techniques [instrumentation, *methods]; 7. Locomotion [physiology]; 8. Motor Skills [*physiology]; 9. Motor Skills Disorders [prevention & control, *rehabilitation]; 10. Randomized Controlled Trials as Topic; 11. *Walking;
MESH terms:
Exercise interventions for cerebral palsy
1. *Exercise; 2. *Motor Skills; 3. *Walking Speed; 4. Cerebral Palsy [*rehabilitation]; 5. Muscle Spasticity [rehabilitation]; 6. Publication Bias; 7. Randomized Controlled Trials as Topic; 8. Resistance Training [*methods];
MESH terms:
Family therapy for autism spectrum disorders
1. *Adaptation, Psychological; 2. *Communication; 3. *Family Therapy; 4. Autism Spectrum Disorder [psychology, *therapy];
MESH terms:
Dietary interventions for recurrent abdominal pain in childhood
1. *Diet, Carbohydrate‐Restricted; 2. Abdominal Pain [*diet therapy]; 3. Dietary Fiber [*therapeutic use]; 4. Fructose; 5. Irritable Bowel Syndrome [diet therapy]; 6. Pain Measurement; 7. Probiotics [*therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Recurrence; 10. Secondary Prevention [methods];
MESH terms:
Psychosocial interventions for recurrent abdominal pain in childhood
1. *Self Disclosure; 2. *Yoga; 3. Abdominal Pain [*therapy]; 4. Cognitive Behavioral Therapy [methods]; 5. Hypnosis [*methods]; 6. Imagery, Psychotherapy; 7. Psychotherapy [*methods]; 8. Randomized Controlled Trials as Topic; 9. Recurrence;
MESH terms:
Group‐based parent training programmes for improving emotional and behavioural adjustment in young children
1. *Infant Behavior; 2. *Mental Health; 3. *Parenting; 4. *Program Evaluation; 5. Child Behavior Disorders [*prevention & control]; 6. Child Development; 7. Child Rearing; 8. Emotions; 9. Randomized Controlled Trials as Topic;
MESH terms:
Aripiprazole for autism spectrum disorders (ASD)
1. Antipsychotic Agents [*therapeutic use]; 2. Aripiprazole [*therapeutic use]; 3. Child Development Disorders, Pervasive [*drug therapy]; 4. Hyperkinesis [drug therapy]; 5. Irritable Mood [drug effects]; 6. Randomized Controlled Trials as Topic;
MESH terms:
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
1. Amphetamines [*therapeutic use]; 2. Attention Deficit Disorder with Hyperactivity [*drug therapy]; 3. Randomized Controlled Trials as Topic;
MESH terms:
Advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well‐being of women who experience intimate partner abuse
1. *Counseling; 2. *Safety; 3. *Social Welfare; 4. Depression [therapy]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Social Work; 8. Spouse Abuse [*prevention & control, psychology, therapy]; 9. Time Factors;
MESH terms:
Intrathecal baclofen for treating spasticity in children with cerebral palsy
1. Baclofen [*administration & dosage]; 2. Cerebral Palsy [*complications]; 3. Injections, Spinal [methods]; 4. Muscle Relaxants, Central [*administration & dosage]; 5. Muscle Spasticity [drug therapy]; 6. Randomized Controlled Trials as Topic;
MESH terms:
Sleep positioning systems for children with cerebral palsy
1. *Cerebral Palsy; 2. *Pain Measurement; 3. *Posture; 4. *Sleep; 5. Hip; 6. Patient Positioning [instrumentation, *methods]; 7. Randomized Controlled Trials as Topic;
MESH terms:
Pharmacological interventions for cognitive decline in people with Down syndrome
1. Acetylcarnitine [adverse effects, therapeutic use]; 2. Antioxidants [*therapeutic use]; 3. Cognition [drug effects]; 4. Cognition Disorders [*drug therapy]; 5. Donepezil; 6. Down Syndrome [*complications]; 7. Indans [adverse effects, therapeutic use]; 8. Memantine [adverse effects, therapeutic use]; 9. Nootropic Agents [adverse effects, *therapeutic use]; 10. Piperidines [adverse effects, therapeutic use]; 11. Randomized Controlled Trials as Topic; 12. Simvastatin [adverse effects, therapeutic use];
MESH terms:
Clozapine for psychotic disorders in adults with intellectual disabilities
1. Antipsychotic Agents [*therapeutic use]; 2. Clozapine [*therapeutic use]; 3. Intellectual Disability [*psychology]; 4. Psychotic Disorders [*drug therapy];
MESH terms:
Screening women for intimate partner violence in healthcare settings
1. *Efficiency, Organizational; 2. *Mass Screening; 3. Emergency Service, Hospital; 4. Maternal Health Services; 5. Pregnant Women; 6. Prenatal Care; 7. Randomized Controlled Trials as Topic; 8. Spouse Abuse [*diagnosis, statistics & numerical data]; 9. Surveys and Questionnaires;
MESH terms:
Non‐speech oral motor treatment for children with developmental speech sound disorders
1. Articulation Disorders [*therapy]; 2. Dysphonia [therapy]; 3. Exercise Therapy [methods]; 4. Language Disorders [*therapy]; 5. Randomized Controlled Trials as Topic; 6. Speech Sound Disorder; 7. Speech Therapy [*methods];
MESH terms:
Food supplementation for improving the physical and psychosocial health of socio‐economically disadvantaged children aged three months to five years
1. *Feeding Methods; 2. *Vulnerable Populations; 3. Child Nutritional Physiological Phenomena; 4. Controlled Before‐After Studies; 5. Energy Intake; 6. Malnutrition [*diet therapy]; 7. Randomized Controlled Trials as Topic; 8. Sex Factors;
MESH terms:
Pharmacological interventions for those who have sexually offended or are at risk of offending
1. Androgen Antagonists [adverse effects, *therapeutic use]; 2. Antipsychotic Agents [adverse effects, *therapeutic use]; 3. Child Abuse, Sexual [*prevention & control]; 4. Desensitization, Psychologic [methods]; 5. Exhibitionism [drug therapy, prevention & control]; 6. Libido [*drug effects]; 7. Randomized Controlled Trials as Topic; 8. Rape [prevention & control]; 9. Recurrence; 10. Sex Offenses [*prevention & control, psychology]; 11. Sexual Behavior [*drug effects];
MESH terms:
Parent‐infant psychotherapy for improving parental and infant mental health
1. *Mental Health; 2. *Parent‐Child Relations; 3. Depression [diagnosis, therapy]; 4. Family Therapy [*methods]; 5. Father‐Child Relations; 6. Mental Disorders [*therapy]; 7. Mother‐Child Relations [psychology]; 8. Object Attachment; 9. Randomized Controlled Trials as Topic; 10. Spouse Abuse;
MESH terms:
Centre‐based day care for children younger than five years of age in low‐ and middle‐income countries
1. *Child Day Care Centers; 2. *Child Development; 3. *Cognition; 4. *Developing Countries; 5. Kenya; 6. Tanzania; 7. Uganda;
MESH terms:
Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents
1. Antidepressive Agents, Tricyclic [*therapeutic use]; 2. Attention Deficit Disorder with Hyperactivity [*drug therapy]; 3. Central Nervous System Stimulants [therapeutic use]; 4. Clonidine [therapeutic use]; 5. Desipramine [therapeutic use]; 6. Methylphenidate [therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Tic Disorders [drug therapy]; 9. Tourette Syndrome [drug therapy];
MESH terms:
The WHO Health Promoting School framework for improving the health and well‐being of students and their academic achievement
1. *Achievement; 2. *Health Behavior; 3. *School Health Services; 4. *Students; 5. *World Health Organization; 6. Bullying; 7. Health Promotion [*methods]; 8. Mental Health; 9. Motor Activity; 10. Obesity [prevention & control]; 11. Randomized Controlled Trials as Topic; 12. Reproductive Health; 13. Substance‐Related Disorders [prevention & control]; 14. Violence;
MESH terms:
Interventions based on the Theory of Mind cognitive model for autism spectrum disorder (ASD)
1. *Theory of Mind; 2. Child Development Disorders, Pervasive [psychology, *therapy]; 3. Emotions; 4. Randomized Controlled Trials as Topic;
MESH terms:
Auditory‐verbal therapy for promoting spoken language development in children with permanent hearing impairments
1. *Language Development; 2. Child Language; 3. Early Intervention, Educational [*methods]; 4. Hearing Loss [*rehabilitation];
MESH terms:
Kinship care for the safety, permanency, and well‐being of children removed from the home for maltreatment
1. *Child Abuse [psychology]; 2. *Child Welfare [psychology]; 3. *Family; 4. *Friends; 5. Child Behavior Disorders [epidemiology]; 6. Child Development; 7. Foster Home Care [*methods, psychology, standards]; 8. Safety;
MESH terms:
Fundoplication versus postoperative medication for gastro‐oesophageal reflux in children with neurological impairment undergoing gastrostomy
1. *Fundoplication; 2. *Gastrostomy; 3. Cerebral Palsy [complications]; 4. Gastroesophageal Reflux [*drug therapy, *surgery]; 5. Gastrointestinal Agents [*therapeutic use]; 6. Postoperative Care; 7. Proton Pump Inhibitors [*therapeutic use];
MESH terms:
Gastrostomy feeding versus oral feeding alone for children with cerebral palsy
1. *Eating; 2. Cerebral Palsy [*complications]; 3. Gastrostomy [adverse effects]; 4. Nutrition Disorders [etiology, *prevention & control];
MESH terms:
Psychoanalytic/psychodynamic psychotherapy for children and adolescents who have been sexually abused
1. *Psychoanalytic Therapy; 2. *Psychotherapy, Psychodynamic; 3. Child Abuse, Sexual [psychology, *therapy]; 4. Sex Offenses [psychology];
MESH terms:
Specially formulated foods for treating children with moderate acute malnutrition in low‐ and middle‐income countries
1. Africa; 2. Bangladesh; 3. *Developing Countries; 4. Dietary Fats [administration & dosage]; 5. Dietary Supplements [adverse effects, *supply & distribution]; 6. Food, Formulated [adverse effects, *standards]; 7. Malnutrition [*diet therapy, mortality]; 8. Randomized Controlled Trials as Topic;
MESH terms:
Specialist home‐based nursing services for children with acute and chronic illnesses
1. Acute Disease [*nursing]; 2. Chronic Disease [*nursing]; 3. Home Care Services, Hospital‐Based [*organization & administration, *standards]; 4. Home Nursing; 5. Hospitalization [statistics & numerical data]; 6. Length of Stay [statistics & numerical data]; 7. Randomized Controlled Trials as Topic;
MESH terms:
Parent‐mediated early intervention for young children with autism spectrum disorders (ASD)
1. Child Development Disorders, Pervasive [psychology, *therapy]; 2. Communication; 3. Early Intervention, Educational [*methods]; 4. Interpersonal Relations; 5. *Parent-Child Relations; 6. *Parents; 7. Randomized Controlled Trials as Topic;
MESH terms:
Day 5 versus day 3 embryo biopsy for preimplantation genetic testing for monogenic/single gene defects
1. *Abortion, Spontaneous; 2. Biopsy; 3. *Genetic Testing [methods]; 4. *Preimplantation Diagnosis [methods]; 5. Stillbirth;
MESH terms:
Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis
1. Antibiotics, Antitubercular [*pharmacology]; 2. Bias; 3. Confidence Intervals; 4. Controlled Before-After Studies; 5. Drug Resistance, Bacterial; 6. HIV Infections [mortality]; 7. Mycobacterium tuberculosis [*drug effects, genetics, *isolation & purification]; 8. Nucleic Acid Amplification Techniques [methods]; 9. Odds Ratio; 10. Randomized Controlled Trials as Topic; 11. Reagent Kits, Diagnostic; 12. Real-Time Polymerase Chain Reaction [*methods]; 13. Rifampin [*pharmacology]; 14. Tuberculosis, Pulmonary [*diagnosis, drug therapy, microbiology, mortality];
MESH terms:
Adenoidectomy for otitis media with effusion (OME) in children
1. Adenoidectomy [adverse effects, methods]; 2. Hemorrhage; 3. *Otitis Media; 4. *Otitis Media with Effusion [surgery]; 5. Quality of Life;
MESH terms:
Pharmacological interventions for prophylaxis of vestibular migraine
1. Antibodies, Monoclonal [therapeutic use]; 2. *Calcium Channel Blockers [therapeutic use]; 3. Headache; 4. *Migraine Disorders [drug therapy, prevention & control];
MESH terms:
Pharmacological interventions for acute attacks of vestibular migraine
1. Anti-Inflammatory Agents, Non-Steroidal [therapeutic use]; 2. Headache; 3. *Migraine Disorders; 4. Tryptamines; 5. Vertigo [drug therapy];
MESH terms:
Non‐pharmacological interventions for prophylaxis of vestibular migraine
1. *Cognitive Behavioral Therapy; 2. Headache; 3. *Migraine Disorders [prevention & control]; 4. Vertigo;
MESH terms:
Pharmacological interventions for persistent postural‐perceptual dizziness (PPPD)
1. Chronic Disease; 2. Dizziness; 3. *Selective Serotonin Reuptake Inhibitors; 4. *Serotonin and Noradrenaline Reuptake Inhibitors;
MESH terms:
Intratympanic corticosteroids for Ménière’s disease
1. Adrenal Cortex Hormones [adverse effects]; 2. Dexamethasone [adverse effects]; 3. *Meniere Disease [complications, drug therapy]; 4. *Tinnitus; 5. Vertigo [drug therapy, etiology];
MESH terms:
Intratympanic gentamicin for Ménière’s disease
1. Aminoglycosides; 2. Anti-Bacterial Agents [adverse effects]; 3. Gentamicins [adverse effects]; 4. *Meniere Disease [complications, drug therapy]; 5. *Tinnitus; 6. Vertigo [drug therapy, etiology];
MESH terms:
Lifestyle and dietary interventions for Ménière’s disease
1. Caffeine; 2. Life Style; 3. *Meniere Disease; 4. Randomized Controlled Trials as Topic; 5. Sodium Chloride; 6. *Tinnitus [etiology, prevention & control]; 7. Vertigo [etiology, prevention & control];
MESH terms:
Surgical interventions for Ménière’s disease
1. *Meniere Disease [surgery]; 2. *Tinnitus [etiology, surgery]; 3. Vertigo [etiology, surgery];
MESH terms:
Systemic pharmacological interventions for Ménière’s disease
1. Adrenal Cortex Hormones; 2. Betahistine; 3. Diuretics; 4. Histamine Antagonists; 5. *Meniere Disease [therapy]; 6. *Tinnitus; 7. Vertigo;
MESH terms:
Positive pressure therapy for Ménière’s disease
1. *Meniere Disease [therapy]; 2. *Otitis Media, Suppurative [drug therapy]; 3. Physical Therapy Modalities; 4. *Tinnitus; 5. Vertigo;
MESH terms:
Tranexamic acid for the reduction of bleeding during functional endoscopic sinus surgery
1. Administration, Intranasal; 2. Adrenal Cortex Hormones [therapeutic use]; 3. Hemorrhage; 4. *Nasal Polyps [drug therapy]; 5. *Tranexamic Acid [therapeutic use];
MESH terms:
Antihistamines for motion sickness
1. *Antiemetics; 2. *Cinnarizine; 3. *Dimenhydrinate; 4. Histamine Antagonists [therapeutic use]; 5. *Motion Sickness [drug therapy]; 6. Scopolamine Derivatives;
MESH terms:
Interventions for the prevention of persistent post‐COVID‐19 olfactory dysfunction
1. Adrenal Cortex Hormones [therapeutic use]; 2. Chronic Disease; 3. *COVID-19 [complications]; 4. *Olfaction Disorders [etiology, prevention & control]; 5. Randomized Controlled Trials as Topic; 6. *Rhinitis [drug therapy]; 7. Smell; 8. Zinc Sulfate;
MESH terms:
Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction
1. Adrenal Cortex Hormones; 2. Anosmia; 3. *COVID-19 [complications]; 4. Expectorants; 5. Luteolin; 6. Nasal Decongestants; 7. Randomized Controlled Trials as Topic; 8. Smell;
MESH terms:
Intratympanic corticosteroids for sudden sensorineural hearing loss
1. Adrenal Cortex Hormones [adverse effects]; 2. Dizziness; 3. *Hearing Loss, Sensorineural [drug therapy]; 4. Pain [drug therapy]; 5. *Tympanic Membrane Perforation [drug therapy]; 6. Vertigo [drug therapy];
MESH terms:
Medical interventions for chronic rhinosinusitis in cystic fibrosis
1. Anti-Bacterial Agents [therapeutic use]; 2. Chronic Disease; 3. *Cystic Fibrosis [drug therapy, therapy]; 4. Quality of Life; 5. *Sinusitis [complications, drug therapy];
MESH terms:
Biologics for chronic rhinosinusitis
1. Anti-Allergic Agents [*therapeutic use]; 2. Antibodies, Monoclonal, Humanized [therapeutic use]; 3. Bias; 4. Biological Products [*therapeutic use]; 5. Chronic Disease; 6. Nasal Obstruction [drug therapy]; 7. Nasal Polyps [drug therapy]; 8. Omalizumab [therapeutic use]; 9. Placebos [therapeutic use]; 10. Quality of Life; 11. Randomized Controlled Trials as Topic; 12. Rhinitis [*drug therapy]; 13. Sinusitis [*drug therapy]; 14. Treatment Outcome;
MESH terms:
Efficacy and safety of rapid tests to guide antibiotic prescriptions for sore throat
1. Anti-Bacterial Agents [*therapeutic use]; 2. Bacteriological Techniques; 3. Drug Prescriptions [statistics & numerical data]; 4. Pharyngitis [*drug therapy, *microbiology, virology]; 5. Randomized Controlled Trials as Topic; 6. Streptococcal Infections [*diagnosis, microbiology]; 7. Streptococcus pyogenes [*isolation & purification];
MESH terms:
Cognitive behavioural therapy for tinnitus
1. Anxiety [therapy]; 2. *Cognitive Behavioral Therapy [methods]; 3. Depression [therapy]; 4. Quality of Life; 5. Randomized Controlled Trials as Topic; 6. Tinnitus [*psychology, *therapy]; 7. Treatment Outcome; 8. Waiting Lists;
MESH terms:
Tranexamic acid for patients with nasal haemorrhage (epistaxis)
1. Administration, Oral; 2. Administration, Topical; 3. Antifibrinolytic Agents [administration & dosage, adverse effects, *therapeutic use]; 4. Blood Transfusion [statistics & numerical data]; 5. Epinephrine [therapeutic use]; 6. Epistaxis [*drug therapy]; 7. Length of Stay; 8. Lidocaine [therapeutic use]; 9. Phenylephrine [therapeutic use]; 10. Placebos [therapeutic use]; 11. Randomized Controlled Trials as Topic; 12. Recurrence; 13. Secondary Prevention [statistics & numerical data]; 14. Tranexamic Acid [administration & dosage, adverse effects, *therapeutic use];
MESH terms:
Sound therapy (using amplification devices and/or sound generators) for tinnitus
1. *Hearing Aids; 2. *Sound; 3. Acoustic Stimulation [*methods]; 4. Randomized Controlled Trials as Topic; 5. Tinnitus [*therapy];
MESH terms:
Antibiotics for acute rhinosinusitis in adults
1. Acute Disease; 2. Anti‐Bacterial Agents [*therapeutic use]; 3. Radiography; 4. Randomized Controlled Trials as Topic; 5. Rhinitis [diagnostic imaging, *drug therapy]; 6. Sinusitis [diagnostic imaging, *drug therapy]; 7. Time Factors;
MESH terms:
Perioperative local anaesthesia for reducing pain following septal surgery
1. Anesthesia, Local [*methods, statistics & numerical data]; 2. Anesthetics, Local [*administration & dosage, adverse effects]; 3. Endotamponade [*methods]; 4. Nasal Septum [*surgery]; 5. Pain Measurement; 6. Pain, Postoperative [*drug therapy]; 7. Randomized Controlled Trials as Topic; 8. Sphenopalatine Ganglion Block; 9. Time Factors; 10. Vomiting [chemically induced];
MESH terms:
Bilateral versus unilateral hearing aids for bilateral hearing impairment in adults
1. *Hearing Aids [statistics & numerical data]; 2. Correction of Hearing Impairment [instrumentation, methods]; 3. Cross‐Over Studies; 4. Hearing Loss, Bilateral [*rehabilitation]; 5. Patient Preference; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Sound Localization; 9. Speech Intelligibility;
MESH terms:
Influenza vaccines for preventing acute otitis media in infants and children
1. Acute Disease; 2. Anti‐Bacterial Agents [therapeutic use]; 3. Influenza Vaccines [adverse effects, *therapeutic use]; 4. Otitis Media [*prevention & control]; 5. Randomized Controlled Trials as Topic;
MESH terms:
Hearing aids for mild to moderate hearing loss in adults
1. *Hearing Aids [adverse effects]; 2. *Quality of Life; 3. Activities of Daily Living; 4. Hearing Loss [*rehabilitation]; 5. Randomized Controlled Trials as Topic;
MESH terms:
Heated, humidified air for the common cold
1. *Air; 2. *Steam [adverse effects]; 3. Common Cold [*therapy, virology]; 4. Heating; 5. Humidity; 6. Picornaviridae Infections [therapy]; 7. Randomized Controlled Trials as Topic; 8. Respiratory Therapy [*methods]; 9. Rhinovirus [physiology]; 10. Virus Shedding;
MESH terms:
Coblation versus other surgical techniques for tonsillectomy
1. Catheter Ablation [adverse effects, *methods]; 2. Hypertrophy [surgery]; 3. Pain, Postoperative [*prevention & control]; 4. Palatine Tonsil [pathology, surgery]; 5. Postoperative Hemorrhage [*prevention & control]; 6. Randomized Controlled Trials as Topic; 7. Sodium Chloride [*therapeutic use]; 8. Tonsillectomy [adverse effects, instrumentation, *methods]; 9. Tonsillitis [surgery];
MESH terms:
Needle aspiration versus incision and drainage for the treatment of peritonsillar abscess
1. *Needles; 2. Drainage [adverse effects, *methods]; 3. Eating; 4. Peritonsillar Abscess [complications, *therapy]; 5. Recurrence; 6. Retreatment; 7. Suction [adverse effects, *methods]; 8. Symptom Assessment; 9. Time Factors;
MESH terms:
Interventions for children with ear discharge occurring at least two weeks following grommet (ventilation tube) insertion
1. Administration, Oral; 2. Adrenal Cortex Hormones [administration & dosage, *therapeutic use]; 3. Anti‐Bacterial Agents [administration & dosage, adverse effects, *therapeutic use]; 4. Drug Therapy, Combination; 5. Middle Ear Ventilation [*adverse effects]; 6. Otitis Media with Effusion [*drug therapy, etiology]; 7. Sodium Chloride [administration & dosage]; 8. Therapeutic Irrigation [methods]; 9. Time Factors;
MESH terms:
Nasal decongestants in monotherapy for the common cold
1. Administration, Intranasal; 2. Common Cold [*drug therapy]; 3. Imidazoles [administration & dosage]; 4. Nasal Decongestants [*administration & dosage, adverse effects]; 5. Oxymetazoline [administration & dosage]; 6. Phenylpropanolamine [administration & dosage]; 7. Pseudoephedrine [administration & dosage]; 8. Randomized Controlled Trials as Topic; 9. Time Factors;
MESH terms:
Interventions to improve hearing aid use in adult auditory rehabilitation
1. Communication; 2. Hearing Aids [*statistics & numerical data]; 3. Hearing Loss [*rehabilitation]; 4. Patient Compliance [statistics & numerical data]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Self Care [methods]; 8. Time Factors;
MESH terms:
Betahistine for symptoms of vertigo
1. Benign Paroxysmal Positional Vertigo [drug therapy]; 2. Betahistine [adverse effects, *therapeutic use]; 3. Randomized Controlled Trials as Topic; 4. Vertigo [*drug therapy];
MESH terms:
Antibiotics for otitis media with effusion in children
1. Anti‐Bacterial Agents [*therapeutic use]; 2. Bacterial Infections [*drug therapy]; 3. Hearing Loss [drug therapy, prevention & control]; 4. Otitis Media with Effusion [*drug therapy, microbiology]; 5. Randomized Controlled Trials as Topic; 6. Time Factors; 7. Treatment Outcome;
MESH terms:
Short‐course oral steroids as an adjunct therapy for chronic rhinosinusitis
1. Administration, Intranasal; 2. Administration, Oral; 3. Adrenal Cortex Hormones [*administration & dosage]; 4. Chemotherapy, Adjuvant; 5. Chronic Disease; 6. Methylprednisolone [*administration & dosage]; 7. Nasal Polyps [*drug therapy]; 8. Randomized Controlled Trials as Topic; 9. Rhinitis [*drug therapy]; 10. Sinusitis [*drug therapy]; 11. Steroids [*administration & dosage]; 12. Time Factors;
MESH terms:
Different types of intranasal steroids for chronic rhinosinusitis
1. Administration, Intranasal; 2. Beclomethasone [administration & dosage]; 3. Chronic Disease; 4. Fluticasone [administration & dosage]; 5. Mometasone Furoate [administration & dosage]; 6. Nasal Polyps [*drug therapy]; 7. Nasal Sprays; 8. Randomized Controlled Trials as Topic; 9. Rhinitis [*drug therapy]; 10. Sinusitis [*drug therapy]; 11. Steroids [*administration & dosage];
MESH terms:
Saline irrigation for chronic rhinosinusitis
1. Administration, Intranasal; 2. Adrenal Cortex Hormones [administration & dosage]; 3. Chronic Disease; 4. Hypertonic Solutions [administration & dosage]; 5. Nasal Polyps [drug therapy]; 6. Nasal Sprays; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Rhinitis [*drug therapy]; 10. Sinusitis [*drug therapy]; 11. Sodium Chloride [*administration & dosage]; 12. Therapeutic Irrigation [methods]; 13. Time Factors;
MESH terms:
Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
1. *Quality of Life; 2. Administration, Intranasal; 3. Adrenal Cortex Hormones [administration & dosage, adverse effects]; 4. Beclomethasone [administration & dosage, adverse effects]; 5. Budesonide [administration & dosage, adverse effects]; 6. Chronic Disease; 7. Fluticasone [administration & dosage, adverse effects]; 8. Mometasone Furoate [administration & dosage, adverse effects]; 9. Nasal Polyps [drug therapy]; 10. Nasal Sprays; 11. Placebos [administration & dosage]; 12. Randomized Controlled Trials as Topic; 13. Rhinitis [*drug therapy]; 14. Severity of Illness Index; 15. Sinusitis [*drug therapy]; 16. Steroids [*administration & dosage, adverse effects];
MESH terms:
Short‐course oral steroids alone for chronic rhinosinusitis
1. Administration, Oral; 2. Chronic Disease; 3. Nasal Polyps [*drug therapy]; 4. Quality of Life; 5. Randomized Controlled Trials as Topic; 6. Rhinitis [*drug therapy]; 7. Severity of Illness Index; 8. Sinusitis [*drug therapy]; 9. Steroids [*administration & dosage, adverse effects]; 10. Time Factors;
MESH terms:
Systemic and topical antibiotics for chronic rhinosinusitis
1. Administration, Intranasal; 2. Administration, Oral; 3. Administration, Topical; 4. Adrenal Cortex Hormones [administration & dosage]; 5. Anti-Bacterial Agents [adverse effects, *therapeutic use]; 6. Chronic Disease; 7. Drug Hypersensitivity [etiology]; 8. Nasal Polyps [*drug therapy]; 9. Nasal Sprays; 10. Quality of Life; 11. Randomized Controlled Trials as Topic; 12. Rhinitis [*drug therapy]; 13. Sinusitis [*drug therapy]; 14. Time Factors;
MESH terms:
Water precautions for prevention of infection in children with ventilation tubes (grommets)
1. *Baths; 2. *Ear Protective Devices; 3. *Middle Ear Ventilation [instrumentation]; 4. *Swimming; 5. *Water; 6. Bacterial Infections [*prevention & control]; 7. Ear Diseases [*prevention & control]; 8. Randomized Controlled Trials as Topic;
MESH terms:
Antihistamines for the common cold
1. Common Cold [*drug therapy]; 2. Histamine Antagonists [*therapeutic use]; 3. Randomized Controlled Trials as Topic; 4. Time Factors;
MESH terms:
Corticosteroids for the common cold
1. Administration, Intranasal; 2. Adrenal Cortex Hormones [*therapeutic use]; 3. Androstadienes [*therapeutic use]; 4. Beclomethasone [*therapeutic use]; 5. Common Cold [*drug therapy]; 6. Fluticasone [therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Treatment Outcome;
MESH terms:
Non‐steroidal anti‐inflammatory drugs for the common cold
1. Anti‐Inflammatory Agents, Non‐Steroidal [*therapeutic use]; 2. Chills [drug therapy]; 3. Common Cold [complications, *drug therapy]; 4. Cough [drug therapy]; 5. Headache Disorders, Secondary [drug therapy]; 6. Randomized Controlled Trials as Topic; 7. Treatment Outcome;
MESH terms:
Virtual reality training for improving the skills needed for performing surgery of the ear, nose or throat
1. *Computer Simulation; 2. Clinical Competence; 3. Computer‐Assisted Instruction [*methods]; 4. Internship and Residency; 5. Operating Rooms; 6. Otolaryngology [*education]; 7. Otorhinolaryngologic Surgical Procedures [*education]; 8. Psychomotor Performance; 9. Randomized Controlled Trials as Topic; 10. Students, Medical;
MESH terms:
Antibiotics for preventing recurrent sore throat
1. Anti‐Bacterial Agents [*therapeutic use]; 2. Pharyngitis [drug therapy, *prevention & control]; 3. Recurrence; 4. Secondary Prevention [*methods];
MESH terms:
Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis
1. Administration, Intranasal [methods]; 2. Betamethasone [*administration & dosage, adverse effects]; 3. Cystic Fibrosis [*complications]; 4. Glucocorticoids [*administration & dosage, adverse effects]; 5. Nasal Polyps [complications, *drug therapy];
MESH terms:
Pharmacological agents for the prevention of vestibular migraine
1. *Vertigo [etiology]; 2. Migraine Disorders [complications, *prevention & control];
MESH terms:
Steroid‐eluting sinus stents for improving symptoms in chronic rhinosinusitis patients undergoing functional endoscopic sinus surgery
1. *Drug‐Eluting Stents; 2. Chronic Disease; 3. Endoscopy [*methods]; 4. Rhinitis [*surgery]; 5. Sinusitis [*surgery]; 6. Steroids [*administration & dosage];
MESH terms:
Antibiotics for acute laryngitis in adults
1. Acute Disease; 2. Anti‐Bacterial Agents [*therapeutic use]; 3. Clarithromycin [therapeutic use]; 4. Depsipeptides; 5. Erythromycin [therapeutic use]; 6. Fusarium; 7. Laryngitis [*drug therapy]; 8. Penicillin V [therapeutic use]; 9. Randomized Controlled Trials as Topic;
MESH terms:
Vestibular rehabilitation for unilateral peripheral vestibular dysfunction
1. *Vestibule, Labyrinth [physiopathology]; 2. Dizziness [rehabilitation]; 3. Exercise Movement Techniques; 4. Postural Balance; 5. Randomized Controlled Trials as Topic; 6. Sensation Disorders [rehabilitation]; 7. Vertigo [rehabilitation]; 8. Vestibular Diseases [physiopathology, *rehabilitation];
MESH terms:
Stereotactic radiotherapy for vestibular schwannoma
1. *Radiosurgery; 2. Neuroma, Acoustic [*surgery];
MESH terms:
The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo
1. *Semicircular Canals; 2. Benign Paroxysmal Positional Vertigo [*rehabilitation]; 3. Exercise Movement Techniques [adverse effects, methods]; 4. Randomized Controlled Trials as Topic;
MESH terms:
Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps
1. Anti‐Bacterial Agents [therapeutic use]; 2. Chronic Disease; 3. Endoscopy; 4. Epistaxis [etiology]; 5. Nasal Obstruction [drug therapy, etiology, surgery]; 6. Nasal Polyps [complications, *drug therapy, *surgery]; 7. Rhinitis [*drug therapy, *surgery]; 8. Sinusitis [*drug therapy, *surgery]; 9. Steroids [therapeutic use];
MESH terms:
Over‐the‐counter (OTC) medications for acute cough in children and adults in community settings
1. Acute Disease; 2. Administration, Oral; 3. Ambulatory Care; 4. Antitussive Agents [*administration & dosage, adverse effects]; 5. Cough [*drug therapy]; 6. Drug Therapy, Combination [methods]; 7. Expectorants [*administration & dosage, adverse effects, therapeutic use]; 8. Histamine H1 Antagonists [*administration & dosage]; 9. Nonprescription Drugs [*administration & dosage, adverse effects]; 10. Randomized Controlled Trials as Topic;
MESH terms:
Surgical interventions for chronic rhinosinusitis with nasal polyps
1. Chronic Disease; 2. Nasal Polyps [complications, *surgery]; 3. Rhinitis [complications, *surgery]; 4. Sinusitis [complications, *surgery];
MESH terms:
Tonsillectomy or adenotonsillectomy versus non‐surgical treatment for chronic/recurrent acute tonsillitis
1. *Adenoidectomy; 2. *Tonsillectomy; 3. Acute Disease; 4. Chronic Disease; 5. Pharyngitis [diagnosis]; 6. Randomized Controlled Trials as Topic; 7. Recurrence; 8. Tonsillitis [surgery, *therapy];
MESH terms:
Amplification with hearing aids for patients with tinnitus and co‐existing hearing loss
1. *Hearing Aids; 2. Hearing Loss [complications, *rehabilitation]; 3. Loudness Perception [*physiology]; 4. Perceptual Masking [physiology]; 5. Randomized Controlled Trials as Topic; 6. Tinnitus [complications, physiopathology, psychology, *therapy];
MESH terms:
Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media
1. Acute Disease; 2. Amoxicillin [*administration & dosage]; 3. Anti‐Bacterial Agents [*administration & dosage]; 4. Clavulanic Acid [*administration & dosage]; 5. Drug Administration Schedule; 6. Drug Therapy, Combination [methods]; 7. Otitis Media [*drug therapy]; 8. Randomized Controlled Trials as Topic;
MESH terms:
Nebulized epinephrine for croup in children
1. Adrenergic alpha‐Agonists [*administration & dosage]; 2. Adrenergic beta‐Agonists [*administration & dosage]; 3. Croup [*drug therapy]; 4. Epinephrine [*administration & dosage]; 5. Length of Stay; 6. Nebulizers and Vaporizers; 7. Racepinephrine [administration & dosage]; 8. Randomized Controlled Trials as Topic;
MESH terms:
Oral rinses, mouthwashes and sprays for improving recovery following tonsillectomy
1. Aerosols; 2. Anesthetics, Local [therapeutic use]; 3. Anti‐Inflammatory Agents [therapeutic use]; 4. Benzydamine [therapeutic use]; 5. Lidocaine [therapeutic use]; 6. Mouthwashes [*therapeutic use]; 7. Pain, Postoperative [*drug therapy]; 8. Postoperative Hemorrhage [*drug therapy]; 9. Randomized Controlled Trials as Topic; 10. Sodium Chloride [therapeutic use]; 11. Tonsillectomy [*adverse effects];
MESH terms:
Steroids for idiopathic sudden sensorineural hearing loss
1. Anti‐Inflammatory Agents [*therapeutic use]; 2. Dexamethasone [therapeutic use]; 3. Glucocorticoids [*therapeutic use]; 4. Hearing Loss, Sensorineural [*drug therapy]; 5. Hearing Loss, Sudden [*drug therapy]; 6. Methylprednisolone [therapeutic use]; 7. Prednisolone [therapeutic use]; 8. Randomized Controlled Trials as Topic;
MESH terms:
Acetaminophen (paracetamol) for the common cold in adults
1. Acetaminophen [*therapeutic use]; 2. Common Cold [*drug therapy]; 3. Nasal Obstruction [drug therapy]; 4. Randomized Controlled Trials as Topic; 5. Rhinitis [drug therapy];
MESH terms:
Intranasal ipratropium bromide for the common cold
1. Administration, Intranasal; 2. Common Cold [*drug therapy]; 3. Ipratropium [adverse effects, *therapeutic use]; 4. Nasal Decongestants [adverse effects, *therapeutic use]; 5. Nasal Obstruction [drug therapy]; 6. Randomized Controlled Trials as Topic;
MESH terms:
Antibiotics for the common cold and acute purulent rhinitis
1. Acute Disease; 2. Anti‐Bacterial Agents [*therapeutic use]; 3. Common Cold [*drug therapy]; 4. Randomized Controlled Trials as Topic; 5. Rhinitis [*drug therapy]; 6. Suppuration [drug therapy]; 7. Treatment Failure;
MESH terms:
Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho‐pulmonary disease
1. Acetylcysteine [adverse effects, *therapeutic use]; 2. Acute Disease; 3. Age Factors; 4. Carbocysteine [adverse effects, *therapeutic use]; 5. Cough [drug therapy]; 6. Expectorants [adverse effects, *therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Respiratory Tract Infections [*drug therapy];
MESH terms:
Autoinflation for hearing loss associated with otitis media with effusion
1. *Eustachian Tube; 2. Acoustic Impedance Tests [methods]; 3. Air; 4. Hearing Loss [etiology, *therapy]; 5. Insufflation [instrumentation, *methods]; 6. Otitis Media with Effusion [complications, *therapy]; 7. Pressure; 8. Randomized Controlled Trials as Topic; 9. Valsalva Maneuver;
MESH terms:
Interventions for the prevention of postoperative ear discharge after insertion of ventilation tubes (grommets) in children
1. Anti‐Bacterial Agents [administration & dosage]; 2. Middle Ear Ventilation [*instrumentation]; 3. Otitis Media [*surgery]; 4. Otitis Media with Effusion [surgery]; 5. Postoperative Complications [drug therapy, *prevention & control]; 6. Randomized Controlled Trials as Topic; 7. Sodium Chloride [administration & dosage]; 8. Steroids [administration & dosage]; 9. Therapeutic Irrigation [methods];
MESH terms:
Surgery for Ménière's disease
1. Endolymphatic Sac [*surgery]; 2. Mastoid [*surgery]; 3. Meniere Disease [*surgery]; 4. Middle Ear Ventilation; 5. Randomized Controlled Trials as Topic;
MESH terms:
Clinical service organisation for adults with atrial fibrillation
1. *Atrial Fibrillation [mortality, therapy]; 2. Bias; 3. Cause of Death; 4. Hospitalization; 5. Quality of Life; 6. *Randomized Controlled Trials as Topic; 7. Stroke [mortality]; 8. Telemedicine;
MESH terms:
Collaborative care approaches for people with severe mental illness
1. Bias; 2. Bipolar Disorder [therapy]; 3. Community Mental Health Services; 4. *Mental Disorders [therapy]; 5. Patient Care Team; 6. *Quality of Life; 7. *Randomized Controlled Trials as Topic; 8. *Schizophrenia [therapy];
MESH terms:
Admission avoidance hospital at home
1. Health Facilities; 2. *Home Care Services; 3. *Hospitalization; 4. *Hospitals; 5. Inpatients; 6. Patient Discharge;
MESH terms:
Primary‐level and community worker interventions for the prevention of mental disorders and the promotion of well‐being in low‐ and middle‐income countries
1. Anxiety [diagnosis]; 2. *Developing Countries; 3. Health Promotion; 4. *Mental Disorders [prevention & control]; 5. Mental Health; 6. Randomized Controlled Trials as Topic;
MESH terms:
Interventions to improve the appropriate use of polypharmacy for older people
1. *Drug-Related Side Effects and Adverse Reactions; 2. Hospitalization; 3. *Pharmaceutical Services; 4. Polypharmacy; 5. Quality of Life;
MESH terms:
Interventions for the uptake of evidence‐based recommendations in acute stroke settings
1. *Brain Ischemia; 2. China; 3. Health Personnel; 4. *Stroke [therapy];
MESH terms:
Acute assessment services for patient flow assistance in hospital emergency departments
1. *Emergency Service, Hospital; 2. Head; 3. Hospitals; 4. MEDLINE; 5. *Physicians;
MESH terms:
Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for treating depression after stroke
1. Brain; 2. *Depression [etiology, therapy]; 3. Psychosocial Intervention; 4. *Stroke [complications, psychology];
MESH terms:
Case management for integrated care of older people with frailty in community settings
1. Case Management; 2. *Delivery of Health Care, Integrated; 3. *Frailty [therapy]; 4. Health Personnel; 5. Hospitalization;
MESH terms:
Medication review in hospitalised patients to reduce morbidity and mortality
1. *Medication Review; 2. Morbidity; 3. Outpatients; 4. Patient Readmission; 5. *Quality of Life; 6. Randomized Controlled Trials as Topic;
MESH terms:
Comprehensive Geriatric Assessment for community‐dwelling, high‐risk, frail, older people
1. Frail Elderly; 2. *Geriatric Assessment; 3. Hospitalization; 4. *Independent Living; 5. Quality of Life;
MESH terms:
Discharge planning from hospital
1. Hospitals; 2. Length of Stay; 3. *Patient Discharge; 4. *Patient Readmission; 5. Patient Satisfaction; 6. Randomized Controlled Trials as Topic;
MESH terms:
Early warning systems and rapid response systems for the prevention of patient deterioration on acute adult hospital wards
1. *Clinical Deterioration; 2. Critical Care; 3. Hospital Mortality; 4. *Hospital Rapid Response Team; 5. Hospitalization; 6. *Hospitals; 7. Length of Stay;
MESH terms:
Routine provision of feedback from patient‐reported outcome measurements to healthcare providers and patients in clinical practice
1. Feedback; 2. *Health Personnel; 3. Patient Reported Outcome Measures; 4. Primary Health Care; 5. *Quality of Life;
MESH terms:
Decision‐support tools via mobile devices to improve quality of care in primary healthcare settings
1. Bias; 2. *Cell Phone; 3. *Decision Support Systems, Clinical; 4. Guideline Adherence; 5. Guidelines as Topic; 6. Health Behavior; 7. Health Personnel; 8. Health Status; 9. *Primary Health Care; 10. *Quality Improvement; 11. *Quality of Health Care; 12. Randomized Controlled Trials as Topic;